FORM OF COMMON STOCK PURCHASE WARRANT To Purchase «Shares» Shares of Common Stock of BIOSANTE PHARMACEUTICALS, INC.Biosante Pharmaceuticals Inc • August 6th, 2003 • Biological products, (no disgnostic substances) • New York
THIS IS TO CERTIFY THAT «Name», or registered assigns (the “Holder”), is entitled, during the Exercise Period (as hereinafter defined), to purchase from BioSante Pharmaceuticals, Inc., a Delaware corporation (the “Company”), the Warrant Stock (as hereinafter defined and subject to adjustment as provided herein), in whole or in part, at a purchase price of $2.15 per share, all on and subject to the terms and conditions hereinafter set forth.
COMMON STOCK AND WARRANT PURCHASE AGREEMENT by and among BioSante Pharmaceuticals, Inc. and the parties named herein on Schedule 1, as Purchasers August 4, 2003Common Stock and Warrant Purchase Agreement • August 6th, 2003 • Biosante Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York
This COMMON STOCK AND WARRANT PURCHASE AGREEMENT (this “Agreement”) is dated as of August 4, 2003, among BioSante Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the purchasers identified on Schedule 1 hereto (each a “Purchaser” and collectively the “Purchasers”).
INVESTOR RIGHTS AGREEMENTInvestor Rights Agreement • August 6th, 2003 • Biosante Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York
This Agreement is being entered into pursuant to the Common Stock and Warrant Purchase Agreement, dated as of the date hereof, by and among the Company and the Purchasers (the “Purchase Agreement”).
